Clinical Trial

The Safety and Efficacy of Roflumilast Foam in HS

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study investigates the efficacy of topical roflumilast foam in patients with HS.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-03 -> 2028-08 2026-07-10
minor Completion pushed: 2028-12 -> 2029-05 2026-07-10
Trial Details
NCT Number NCT07263230
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Hidradenitis Suppurativa (HS)
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2028-08 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-09